Results 31 to 40 of about 43,404 (216)

Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study

open access: yesFrontiers in Pharmacology, 2022
Aims: We aimed to assess the impact of extracorporeal membrane oxygenation (ECMO) on voriconazole exposure.Methods: Adult critically ill patients with or without ECMO support receiving intravenous voriconazole therapy were included in this retrospective ...
Qinghua Ye   +11 more
doaj   +1 more source

Voriconazole

open access: yesReactions Weekly, 2006
Voriconazole (VRZ) is a second-generation triazole antifungal agent active against many species of Aspergillus and Candida and acts by inhibiting ergosterol synthesis. VRZ has less nephrotoxicity and less infusion-related toxicity than that of Amphotericin B. Oral and parental formulation have similar pharmacokinetics and thus oral formulation shortens
Rahul, Naithani, Rajat, Kumar
openaire   +3 more sources

Voriconazole-induced arthritis, enthesitis and periostitis

open access: yesProceedings of Singapore Healthcare, 2023
Voriconazole is a fluoride-containing anti-fungal. Prolonged exposure can result in fluoride deposition within the bone extracellular matrix, resulting in periostitis and arthritis.
Adrian Mark Masnammany   +3 more
doaj   +1 more source

Impact of glucuronide interferences on therapeutic drug monitoring of posaconazole by tandem mass spectrometry [PDF]

open access: yes, 2010
Background: Posaconazole is a novel antifungal drug for oral application intended especially for therapy of invasive mycoses. Due to variable gastrointestinal absorption, adverse side effects, and suspected drug-drug interactions, therapeutic drug ...
Burghardt, Stephan   +4 more
core   +1 more source

Allergic bronchopulmonary aspergillosis: diagnostic and treatment challenges [PDF]

open access: yes, 2016
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder, occurring mostly in asthmatic and cystic fibrosis patients, caused by an abnormal T-helper 2 lymphocyte response of the host to Aspergillus fumigatus antigens.
CINICOLA, BIANCA LAURA   +3 more
core   +1 more source

Drug reservoir function of voriconazole impregnated human amniotic membrane: An in vitro study

open access: yesIndian Journal of Ophthalmology, 2021
Purpose: Earlier our group has demonstrated the drug reservoir function of the human amniotic membrane (HAM) using stable moxifloxacin and fortified cefazolin ophthalmic formulations and found it as a suitable tool to deliver drugs for an extended ...
Manali Hazarika   +2 more
doaj   +1 more source

Intracameral Injection of Bevacizumab for the Treatment of Neovascular Glaucoma [PDF]

open access: yes, 2011
Purpose: To assess the duration of the effect of intracameral bevacizumab in patients presenting with rubeosis iridis and neovascular glaucoma (NVG). Methods: Retrospective analysis of 24 consecutive eyes of 24 patients with decompensated NVG (> 21 mm Hg)
Haritoglou, Christos   +3 more
core   +1 more source

Single dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model [PDF]

open access: yes, 2013
Conventional MIC testing of amphotericin B results in narrow MIC ranges challenging the detection of resistant strains. In order to discern amphotericin B pharmacodynamics, the in vitro activity of amphotericin B was studied against Aspergillus isolates ...
Al-Saigh, Rafal   +5 more
core   +1 more source

A rare case of voriconazole-induced vertebral periostitis in a patient with invasive aspergillus spondylodiscitis

open access: yesIndian Spine Journal, 2022
The author illustrates the first ever reported case of voriconazole-induced periostitis of vertebral body. A 66-year-old immunocompetent male patient was diagnosed with multilevel invasive aspergillus spondylodiscitis of dorsal spine and was put on long ...
Alok Jain   +3 more
doaj   +1 more source

Efficacy of voriconazole on leishmaniasis by Leishmania major: An in vitro and in vivo study

open access: yesAsian Pacific Journal of Tropical Medicine, 2018
Objective: To appraise the activity of voriconazole against Leishmania major (L. major) in vitro and its effectiveness on wound regeneration in cutaneous leishmaniasis in BALB/c mice.
Ahmad Oryan   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy